Genvor Inc
GNVR· OTC
Filed Aug 14, 2026 · 10-Q · 45 days after period end · 0001213900-26-089463
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Net Income | -$2.56M | -$397.78K | -$601.88K | -$215.03K |
| EPS Diluted | -$0.07 | -$0.01 | -$0.03 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Genvor Inc · CIK 1792941 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end